Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer
NCT01229618
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Hyperpolarized Pyruvate (13C) injection
Sponsor
University of California, San Francisco
Collaborators
[object Object]